Form EFFECT Ambrx Biopharma Inc.

June 18, 2021 6:07 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 17, 2021 5:30 P.M.
Form: F-1
CIK: 0001836056
Company Name: Ambrx Biopharma Inc.
File Number: 333-256639


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings